Literature DB >> 9799886

Medical treatment of erectile dysfunction.

N Burns-Cox1, C Gingell.   

Abstract

There has been a tremendous increase in demand for the treatment of erectile dysfunction in the last 10 years. This has occurred partly because of a greater understanding and awareness by both the general public and clinicians, and also because there now exists a range of effective treatments. The choice of treatments is increasing rapidly and novel delivery systems which may be more patient-friendly than intracavernosal injections are now becoming available. We review the published data on effectiveness and safety of the currently available treatments and discuss recent advances in oral therapy, as these drugs are likely to become available in the near future.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9799886      PMCID: PMC2360949          DOI: 10.1136/pgmj.74.872.336

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  44 in total

1.  The control of deviant sexual behaviour by drugs. I. Behavioural changes following oestrogens and anti-androgens.

Authors:  J Bancroft; G Tennent; K Loucas; J Cass
Journal:  Br J Psychiatry       Date:  1974-09       Impact factor: 9.319

2.  Intracavernous injection of papaverine for erectile failure.

Authors:  R Virag
Journal:  Lancet       Date:  1982-10-23       Impact factor: 79.321

3.  Changes in erectile responsiveness during androgen replacement therapy.

Authors:  J Bancroft; F C Wu
Journal:  Arch Sex Behav       Date:  1983-02

4.  Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study.

Authors:  N E Skakkebaek; J Bancroft; D W Davidson; P Warner
Journal:  Clin Endocrinol (Oxf)       Date:  1981-01       Impact factor: 3.478

5.  Testosterone therapy for low sexual interest and erectile dysfunction in men: a controlled study.

Authors:  R O'Carroll; J Bancroft
Journal:  Br J Psychiatry       Date:  1984-08       Impact factor: 9.319

6.  The nature of androgen action on male sexuality: a combined laboratory-self-report study on hypogonadal men.

Authors:  M Kwan; W J Greenleaf; J Mann; L Crapo; J M Davidson
Journal:  J Clin Endocrinol Metab       Date:  1983-09       Impact factor: 5.958

7.  Effects of androgen on sexual behavior in hypogonadal men.

Authors:  J M Davidson; C A Camargo; E R Smith
Journal:  J Clin Endocrinol Metab       Date:  1979-06       Impact factor: 5.958

8.  Followup results of a combination of calcitonin gene-related peptide and prostaglandin E1 in the treatment of erectile dysfunction.

Authors:  M Djamilian; C G Stief; M Kuczyk; U Jonas
Journal:  J Urol       Date:  1993-05       Impact factor: 7.450

9.  Double-blind group comparative study of testosterone undecanoate and mesterolone in hypogonadal male patients.

Authors:  M Luisi; F Franchi
Journal:  J Endocrinol Invest       Date:  1980 Jul-Sep       Impact factor: 4.256

10.  Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men.

Authors:  R Virag; P Bouilly; D Frydman
Journal:  Lancet       Date:  1985-01-26       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.